Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Fractyl Health, Inc. (GUTS) just unveiled an update.
Fractyl Health, Inc. has announced a significant milestone with the FDA granting it Investigational Device Exemption to explore the effectiveness of its Revita device in sustaining weight loss after patients stop using GLP-1 receptor agonist drugs. This development, along with other recent updates, has been incorporated into a new corporate presentation, accessible on the company’s investor relations website. This move marks a promising step forward for the company in the weight management medical device market.
Learn more about GUTS stock on TipRanks’ Stock Analysis page.